Latest Insider Transactions at Adma Biologics, Inc. (ADMA)
This section provides a real-time view of insider transactions for Adma Biologics, Inc. (ADMA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ADMA BIOLOGICS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ADMA BIOLOGICS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 22
2024
|
Adam S Grossman President and CEO |
SELL
Open market or private sale
|
Direct |
48,967
-2.4%
|
$1,028,307
$21.1 P/Share
|
|
Nov 22
2024
|
Brad L. Tade CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
15,000
-7.0%
|
$315,000
$21.15 P/Share
|
|
Sep 30
2024
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,752
-1.06%
|
$413,288
$19.99 P/Share
|
|
Sep 30
2024
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
SELL
Payment of exercise price or tax liability
|
Direct |
2,647
-0.59%
|
$50,293
$19.99 P/Share
|
|
Sep 09
2024
|
Lawrence P. Guiheen |
SELL
Open market or private sale
|
Direct |
9,000
-5.52%
|
$162,000
$18.47 P/Share
|
|
Sep 09
2024
|
Lawrence P. Guiheen |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+5.23%
|
$90,000
$10.8 P/Share
|
|
Aug 30
2024
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
SELL
Open market or private sale
|
Direct |
24,150
-5.1%
|
$386,400
$16.9 P/Share
|
|
Aug 30
2024
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
BUY
Exercise of conversion of derivative security
|
Direct |
24,150
+1.28%
|
$72,450
$3.9 P/Share
|
|
Aug 29
2024
|
Jerrold B Grossman |
SELL
Open market or private sale
|
Direct |
136,861
-22.65%
|
$2,326,637
$17.27 P/Share
|
|
Aug 29
2024
|
Jerrold B Grossman |
BUY
Exercise of conversion of derivative security
|
Direct |
136,861
+6.61%
|
$821,166
$6.81 P/Share
|
|
Aug 27
2024
|
Adam S Grossman President and CEO |
SELL
Open market or private sale
|
Direct |
389,356
-15.9%
|
$6,619,052
$17.29 P/Share
|
|
Aug 27
2024
|
Adam S Grossman President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
389,356
+7.18%
|
$1,168,068
$3.14 P/Share
|
|
Aug 26
2024
|
Adam S Grossman President and CEO |
SELL
Open market or private sale
|
Direct |
236,889
-10.31%
|
$4,027,113
$17.69 P/Share
|
|
Aug 26
2024
|
Adam S Grossman President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
236,889
+2.1%
|
$1,421,334
$6.9 P/Share
|
|
Aug 23
2024
|
Young Kwon |
SELL
Open market or private sale
|
Direct |
60,000
-19.9%
|
$1,080,000
$18.26 P/Share
|
|
Jul 24
2024
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
SELL
Payment of exercise price or tax liability
|
Direct |
2,502
-0.55%
|
$32,526
$13.58 P/Share
|
|
Jul 24
2024
|
Brad L. Tade CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
72,400
+25.24%
|
-
|
|
Jun 30
2024
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,752
-1.05%
|
$239,272
$11.18 P/Share
|
|
Jun 30
2024
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
SELL
Payment of exercise price or tax liability
|
Direct |
2,085
-0.46%
|
$22,935
$11.18 P/Share
|
|
Jun 14
2024
|
Adam S Grossman President and CEO |
SELL
Open market or private sale
|
Direct |
100,000
-4.58%
|
$1,000,000
$10.72 P/Share
|
|
Jun 14
2024
|
Adam S Grossman President and CEO |
SELL
Bona fide gift
|
Direct |
10,000
-0.46%
|
-
|
|
Jun 14
2024
|
Adam S Grossman President and CEO |
SELL
Other acquisition or disposition
|
Direct |
460,000
-17.35%
|
$1,380,000
$3.21 P/Share
|
|
Apr 01
2024
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
BUY
Grant, award, or other acquisition
|
Direct |
192,320
+38.71%
|
-
|
|
Mar 31
2024
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,752
-0.81%
|
$130,512
$6.6 P/Share
|
|
Mar 31
2024
|
Kaitlin M. Kestenberg Messina COO and SVP, Compliance |
SELL
Payment of exercise price or tax liability
|
Direct |
2,085
-1.82%
|
$12,510
$6.6 P/Share
|
|
Mar 19
2024
|
Steve Elms |
SELL
Open market or private sale
|
Indirect |
411,829
-16.29%
|
$2,470,974
$6.08 P/Share
|
|
Mar 18
2024
|
Steve Elms |
SELL
Open market or private sale
|
Indirect |
49,887
-1.94%
|
$299,322
$6.01 P/Share
|
|
Mar 15
2024
|
Steve Elms |
SELL
Open market or private sale
|
Indirect |
183,008
-6.63%
|
$1,098,048
$6.01 P/Share
|
|
Mar 14
2024
|
Steve Elms |
SELL
Open market or private sale
|
Indirect |
448,276
-13.97%
|
$2,689,656
$6.05 P/Share
|
|
Mar 13
2024
|
Steve Elms |
SELL
Open market or private sale
|
Indirect |
407,000
-11.26%
|
$2,442,000
$6.21 P/Share
|
|
Mar 07
2024
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
28,763
-1.06%
|
$172,578
$6.16 P/Share
|
|
Mar 07
2024
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,965
-2.36%
|
$101,790
$6.16 P/Share
|
|
Mar 06
2024
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
55,003
-2.0%
|
$330,018
$6.12 P/Share
|
|
Mar 06
2024
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,677
-2.26%
|
$100,062
$6.12 P/Share
|
|
Feb 29
2024
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,935
-0.67%
|
$24,675
$5.36 P/Share
|
|
Feb 29
2024
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,588
-0.35%
|
$47,940
$5.36 P/Share
|
|
Feb 26
2024
|
Steve Elms |
BUY
Grant, award, or other acquisition
|
Direct |
24,040
+23.92%
|
-
|
|
Feb 26
2024
|
Bryant Fong |
BUY
Grant, award, or other acquisition
|
Direct |
24,040
+22.26%
|
-
|
|
Feb 26
2024
|
Lawrence P. Guiheen |
BUY
Grant, award, or other acquisition
|
Direct |
24,040
+13.51%
|
-
|
|
Feb 26
2024
|
Young Kwon |
BUY
Grant, award, or other acquisition
|
Direct |
24,040
+7.39%
|
-
|
|
Feb 26
2024
|
Jerrold B Grossman |
BUY
Grant, award, or other acquisition
|
Direct |
24,040
+4.89%
|
-
|
|
Feb 26
2024
|
Adam S Grossman President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
557,728
+16.78%
|
-
|
|
Feb 26
2024
|
Alison Cecily Finger |
BUY
Grant, award, or other acquisition
|
Direct |
24,040
+50.0%
|
-
|
|
Feb 25
2024
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
22,457
-1.01%
|
$112,285
$5.26 P/Share
|
|
Feb 25
2024
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,257
-1.1%
|
$41,285
$5.26 P/Share
|
|
Dec 31
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,057
-1.02%
|
$92,228
$4.52 P/Share
|
|
Dec 31
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,908
-2.21%
|
$67,632
$4.52 P/Share
|
|
Sep 30
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,268
-1.95%
|
$45,804
$3.58 P/Share
|
|
Sep 30
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
18,718
-0.82%
|
$56,154
$3.58 P/Share
|
|
Aug 30
2023
|
Jerrold B Grossman |
BUY
Open market or private purchase
|
Direct |
130,000
+22.68%
|
$390,000
$3.71 P/Share
|